Envista Holdings Corporation (NVST) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Oct 02 2026 to Sep 26 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Envista Holdings Corporation  (NYSE: NVST)


Envista Holdings's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Envista Holdings's ROI in the third quarter of 2026?
Envista Holdings Corporation achieved a return on average invested assets (ROI) of 13.56 % in its third quarter of 2026, this is above NVST's average return on investment of -1.14%.
Envista Holdings Corporations investments during the 12 months ending in the third quarter of 2026 are valued at $4 billion

ROI has improved compared to 2.06% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 168 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1309 to 2238.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Oct 02 2026)
III. Quarter		 (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 26 2025)
III. Quarter
Y / Y Investment Change TTM 5.84 % 5.29 % 5.43 % -2.42 % -11.09 %
Y / Y Net Income Change TTM 4041.18 % 76.58 % 147.08 % 400 % 86.59 %
Investment (TTM) in Millions 4,795 4,790 4,519 4,591 4,534
Return On Investment (TTM) 13.56 % 2.06 % 1.49 % 1.04 % 0.35 %
NVST's Overall Ranking # 2238 # 1309 # 1676 # 2115 #
Seq. Investment Change TTM 1.42 % 1.13 % 1.03 % 2.14 % 0.89 %
Seq. Net Income Change TTM 566.95 % 40.32 % 44.04 % 207.19 % -71.56 %
Net Income (TTM) in Millions 634 95 68 47 15

NVST Company Profile >> Back to NVST Roi Comparisons >> See Annual NVST Return On Investment



Return On Investment NVST's Ranking
Within: No.
Industry # 57
Sector # 169
Overall # 2238

Return On Investment Statistics
High Average Low
6.8 %
-1.14 %
-26.92 %
(Oct 01 2021)   (Sep 27 2024)







Financial Statements
Envista Holdings's III. Quarter Investments $ 4,795 Millions NVST's Balance sheet
Envista Holdings's III. Quarter Income $ 508 Millions Quarterly NVST's Income Statement
NVST's Income by Division See NVST's Income by Division


NVST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 4,555 4,213 5,572 5,078 5,366
Y / Y Investment Growth 8.11 % -24.39 % 9.74 % -5.38 % 3.36 %
Net Income in Millions 47 -1,119 -100 243 341
Y / Y Net Income Growth - - - -28.6 % 922.52 %
Annual Return On Investment 1.03 % -26.55 % -1.8 % 4.79 % 6.35 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 1.03 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NVST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NVST's Competitors
Subscribers only: Roi for Envista Holdings's Suppliers
Subscribers only: Return On Investment for NVST's Customers

Other Ratios
NVST's Roa NVST's Inventory Turnover Ratio NVST's Growth Rates NVST's Dividend Statistics
NVST's Profitability Ratios NVST's Asset Turnover Ratio NVST's Dividend Growth
NVST's Roe NVST's Valuation Ratios NVST's Financial Strength Ratios NVST's Dividend Payout Ratio



Companies with similar Return On Investment at Oct 02 2026, within Healthcare Sector ROI
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %

Date modified: 2026-11-07T13:24:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.